Summaries & Associations of Study Results
TR-018 IPD (3,3'-Iminobis-1-propanol dimethanesulfonate (ester) hydrochloride)
Target Organs and Levels of Evidence
NTP Technical Report Number 018
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| IPD (3,3'-IMINOBIS-1-PROPANOL DIMETHANESULFONATE (ESTER) HYDROCHLORIDE) 3458-22-8 |
11/28/77 | ANTICANCER DRUG | Intraperitoneal Injection R: 0,12,24,48, M: 0,20,40 MG/KG/35 PER GROUP | Southern Research Institute |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: EQUIVOCAL | MESOTHELIUM (ABDOMINAL CAVITY/TUNICA VAGINALIS) : FIBROMA OR FIBROSARCOMA OR SARCOMA | |||
| FR: EQUIVOCAL | MESOTHELIUM (ABDOMINAL CAVITY/TUNICA VAGINALIS) : FIBROSARCOMA OR SARCOMA | |||
| MM: EQUIVOCAL | SUBCUTANEOUS TISSUE (SQUAMOUS CELL CARCINOMA) | |||
| HEMATOPOIETIC SYSTEM (LYMPHOMA) | ||||
| FM: EQUIVOCAL | SUBCUTANEOUS TISSUE (SQUAMOUS CELL CARCINOMA) | |||
| HEMATOPOIETIC SYSTEM (LYMPHOMA) | ||||
Web page last updated on February 10, 2006
